| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 94 | 2026 | 1018 | 17.560 |
Why?
|
| Heart Failure | 61 | 2026 | 2325 | 8.070 |
Why?
|
| Heart Transplantation | 40 | 2025 | 839 | 6.650 |
Why?
|
| Heart Defects, Congenital | 46 | 2025 | 1881 | 5.510 |
Why?
|
| Fontan Procedure | 19 | 2021 | 180 | 4.660 |
Why?
|
| Prosthesis Implantation | 9 | 2019 | 151 | 3.300 |
Why?
|
| Pulmonary Artery | 18 | 2024 | 437 | 3.030 |
Why?
|
| Heart Ventricles | 25 | 2026 | 758 | 2.810 |
Why?
|
| Cardiomyopathy, Dilated | 7 | 2022 | 198 | 2.470 |
Why?
|
| Child | 114 | 2025 | 26174 | 1.910 |
Why?
|
| Treatment Outcome | 83 | 2025 | 12821 | 1.870 |
Why?
|
| Cardiac Surgical Procedures | 22 | 2025 | 1160 | 1.820 |
Why?
|
| Heart Septal Defects, Ventricular | 10 | 2018 | 133 | 1.710 |
Why?
|
| Extracorporeal Membrane Oxygenation | 12 | 2025 | 683 | 1.600 |
Why?
|
| Transposition of Great Vessels | 6 | 2020 | 120 | 1.570 |
Why?
|
| Humans | 218 | 2026 | 130085 | 1.550 |
Why?
|
| Pulmonary Atresia | 4 | 2025 | 48 | 1.520 |
Why?
|
| Registries | 16 | 2025 | 1607 | 1.490 |
Why?
|
| Child, Preschool | 75 | 2025 | 15005 | 1.470 |
Why?
|
| Heart | 9 | 2023 | 659 | 1.440 |
Why?
|
| Infant | 76 | 2025 | 13269 | 1.420 |
Why?
|
| Prosthesis Design | 22 | 2024 | 623 | 1.370 |
Why?
|
| Heart, Artificial | 3 | 2019 | 46 | 1.340 |
Why?
|
| Retrospective Studies | 83 | 2025 | 17541 | 1.330 |
Why?
|
| Ventricular Function, Left | 10 | 2022 | 546 | 1.330 |
Why?
|
| Ventricular Dysfunction, Right | 4 | 2020 | 79 | 1.310 |
Why?
|
| Cardiomyopathies | 6 | 2025 | 521 | 1.280 |
Why?
|
| Vascular Diseases | 3 | 2022 | 147 | 1.270 |
Why?
|
| Device Removal | 6 | 2019 | 222 | 1.210 |
Why?
|
| Adolescent | 67 | 2025 | 20800 | 1.120 |
Why?
|
| Heart Atria | 6 | 2020 | 340 | 1.110 |
Why?
|
| Time Factors | 36 | 2025 | 6165 | 1.090 |
Why?
|
| Coronary Circulation | 5 | 2022 | 188 | 1.080 |
Why?
|
| Reoperation | 18 | 2021 | 813 | 1.020 |
Why?
|
| Heart Valve Diseases | 4 | 2021 | 165 | 0.970 |
Why?
|
| Heart Septal Defects, Atrial | 5 | 2020 | 138 | 0.950 |
Why?
|
| Waiting Lists | 6 | 2025 | 251 | 0.920 |
Why?
|
| Coronary Vessels | 5 | 2024 | 523 | 0.900 |
Why?
|
| Graft Rejection | 5 | 2024 | 556 | 0.900 |
Why?
|
| Tricuspid Atresia | 2 | 2018 | 13 | 0.890 |
Why?
|
| Ebstein Anomaly | 4 | 2013 | 29 | 0.880 |
Why?
|
| Female | 106 | 2025 | 70246 | 0.850 |
Why?
|
| Surgeons | 3 | 2023 | 289 | 0.850 |
Why?
|
| Arterial Switch Operation | 3 | 2020 | 23 | 0.840 |
Why?
|
| Prosthesis-Related Infections | 3 | 2018 | 194 | 0.820 |
Why?
|
| Allografts | 3 | 2024 | 220 | 0.810 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2020 | 424 | 0.810 |
Why?
|
| Palliative Care | 4 | 2021 | 445 | 0.800 |
Why?
|
| Thrombosis | 3 | 2022 | 498 | 0.800 |
Why?
|
| Vascular Surgical Procedures | 10 | 2021 | 535 | 0.790 |
Why?
|
| Tricuspid Valve | 4 | 2016 | 59 | 0.780 |
Why?
|
| Male | 96 | 2025 | 64386 | 0.780 |
Why?
|
| Coronary Vessel Anomalies | 5 | 2024 | 281 | 0.780 |
Why?
|
| Infant, Newborn | 40 | 2026 | 8554 | 0.760 |
Why?
|
| Mitral Valve | 5 | 2021 | 244 | 0.750 |
Why?
|
| Cannula | 2 | 2020 | 31 | 0.750 |
Why?
|
| Elementary Particles | 5 | 2014 | 10 | 0.740 |
Why?
|
| Hypoplastic Left Heart Syndrome | 6 | 2026 | 263 | 0.740 |
Why?
|
| Hospitals, Pediatric | 5 | 2019 | 800 | 0.740 |
Why?
|
| Follow-Up Studies | 25 | 2025 | 5167 | 0.720 |
Why?
|
| Ventricular Septum | 1 | 2022 | 16 | 0.710 |
Why?
|
| Lung Transplantation | 6 | 2022 | 356 | 0.690 |
Why?
|
| Pericardium | 3 | 2007 | 103 | 0.670 |
Why?
|
| Postoperative Complications | 14 | 2024 | 3114 | 0.670 |
Why?
|
| Cardiac Catheterization | 7 | 2022 | 631 | 0.660 |
Why?
|
| Tissue and Organ Procurement | 5 | 2020 | 253 | 0.660 |
Why?
|
| Aorta, Thoracic | 11 | 2024 | 527 | 0.640 |
Why?
|
| Truncus Arteriosus, Persistent | 3 | 2021 | 19 | 0.640 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2021 | 178 | 0.630 |
Why?
|
| Recovery of Function | 8 | 2024 | 446 | 0.620 |
Why?
|
| Models, Cardiovascular | 3 | 2021 | 165 | 0.620 |
Why?
|
| Quantum Theory | 6 | 2014 | 19 | 0.620 |
Why?
|
| Endocarditis, Bacterial | 2 | 2018 | 127 | 0.610 |
Why?
|
| Macrophages | 1 | 2024 | 659 | 0.610 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 51 | 0.600 |
Why?
|
| Graft Survival | 7 | 2024 | 462 | 0.600 |
Why?
|
| Endocardial Cushion Defects | 2 | 2009 | 7 | 0.590 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 34 | 0.590 |
Why?
|
| Abnormalities, Multiple | 8 | 2024 | 964 | 0.580 |
Why?
|
| Survival Rate | 18 | 2025 | 2107 | 0.580 |
Why?
|
| Cardiopulmonary Bypass | 7 | 2021 | 357 | 0.580 |
Why?
|
| Stroke | 2 | 2024 | 1059 | 0.570 |
Why?
|
| Hemodynamics | 8 | 2022 | 810 | 0.570 |
Why?
|
| Single Photon Emission Computed Tomography Computed Tomography | 1 | 2018 | 7 | 0.570 |
Why?
|
| Materials Testing | 1 | 2018 | 73 | 0.560 |
Why?
|
| Stents | 3 | 2016 | 784 | 0.540 |
Why?
|
| Heparin | 3 | 2022 | 205 | 0.530 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 122 | 0.520 |
Why?
|
| Age Factors | 14 | 2020 | 2822 | 0.520 |
Why?
|
| Prosthesis Failure | 4 | 2019 | 160 | 0.520 |
Why?
|
| Hemostasis | 1 | 2017 | 76 | 0.520 |
Why?
|
| Ventricular Function | 2 | 2017 | 82 | 0.520 |
Why?
|
| Heart Valve Prosthesis | 4 | 2020 | 302 | 0.510 |
Why?
|
| Surgical Fixation Devices | 1 | 2017 | 3 | 0.510 |
Why?
|
| Equipment Design | 7 | 2025 | 509 | 0.510 |
Why?
|
| Thoracic Surgery | 3 | 2025 | 163 | 0.510 |
Why?
|
| Titanium | 1 | 2017 | 25 | 0.500 |
Why?
|
| Anticoagulants | 4 | 2022 | 598 | 0.500 |
Why?
|
| Young Adult | 23 | 2025 | 9981 | 0.500 |
Why?
|
| Anthracyclines | 1 | 2017 | 46 | 0.500 |
Why?
|
| Wound Closure Techniques | 1 | 2017 | 26 | 0.500 |
Why?
|
| Adult | 46 | 2025 | 31011 | 0.490 |
Why?
|
| Abscess | 2 | 2009 | 137 | 0.490 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2016 | 13 | 0.480 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 122 | 0.470 |
Why?
|
| Heart Diseases | 2 | 2020 | 499 | 0.470 |
Why?
|
| Rectus Abdominis | 1 | 2015 | 11 | 0.470 |
Why?
|
| Miniaturization | 4 | 2024 | 26 | 0.460 |
Why?
|
| Atrial Pressure | 1 | 2015 | 6 | 0.460 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 22 | 0.450 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 36 | 0.440 |
Why?
|
| Risk Factors | 26 | 2025 | 10960 | 0.430 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 44 | 0.430 |
Why?
|
| Aortic Valve Insufficiency | 5 | 2019 | 147 | 0.410 |
Why?
|
| Double Outlet Right Ventricle | 3 | 2010 | 19 | 0.410 |
Why?
|
| Risk Assessment | 13 | 2025 | 3677 | 0.400 |
Why?
|
| Nuclear Physics | 4 | 2014 | 11 | 0.400 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2013 | 42 | 0.400 |
Why?
|
| Shock, Cardiogenic | 3 | 2024 | 173 | 0.390 |
Why?
|
| Compassionate Use Trials | 1 | 2013 | 17 | 0.380 |
Why?
|
| Allied Health Personnel | 1 | 2013 | 33 | 0.380 |
Why?
|
| Dextrocardia | 1 | 2012 | 6 | 0.360 |
Why?
|
| Aortic Valve | 4 | 2019 | 454 | 0.350 |
Why?
|
| Pediatrics | 3 | 2020 | 1242 | 0.340 |
Why?
|
| Myocardium | 6 | 2025 | 859 | 0.340 |
Why?
|
| Hemolysis | 3 | 2021 | 86 | 0.340 |
Why?
|
| Lung Diseases | 1 | 2015 | 397 | 0.330 |
Why?
|
| Subclavian Artery | 1 | 2011 | 65 | 0.330 |
Why?
|
| Tissue Donors | 4 | 2024 | 506 | 0.330 |
Why?
|
| Tunica Media | 1 | 2010 | 15 | 0.330 |
Why?
|
| United States | 18 | 2025 | 11896 | 0.320 |
Why?
|
| Scoliosis | 2 | 2018 | 147 | 0.320 |
Why?
|
| Texas | 9 | 2020 | 3655 | 0.320 |
Why?
|
| Klebsiella oxytoca | 1 | 2009 | 2 | 0.310 |
Why?
|
| Drug Monitoring | 1 | 2013 | 289 | 0.310 |
Why?
|
| Vascular Malformations | 1 | 2011 | 103 | 0.310 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2010 | 36 | 0.310 |
Why?
|
| Scimitar Syndrome | 2 | 2021 | 51 | 0.310 |
Why?
|
| Klebsiella Infections | 1 | 2009 | 57 | 0.300 |
Why?
|
| Norwood Procedures | 2 | 2020 | 97 | 0.290 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2009 | 73 | 0.290 |
Why?
|
| Antithrombins | 3 | 2022 | 49 | 0.290 |
Why?
|
| Catheterization | 1 | 2010 | 225 | 0.280 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2025 | 161 | 0.280 |
Why?
|
| Preoperative Care | 3 | 2025 | 357 | 0.280 |
Why?
|
| Patient Care Team | 1 | 2013 | 558 | 0.280 |
Why?
|
| Heart Septal Defects | 2 | 2018 | 42 | 0.280 |
Why?
|
| Tachycardia | 2 | 2022 | 70 | 0.270 |
Why?
|
| Aortic Coarctation | 4 | 2015 | 98 | 0.270 |
Why?
|
| Surgical Flaps | 2 | 2009 | 179 | 0.270 |
Why?
|
| Outpatients | 2 | 2022 | 262 | 0.270 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2020 | 46 | 0.260 |
Why?
|
| Vasodilator Agents | 2 | 2019 | 197 | 0.240 |
Why?
|
| Donor Selection | 2 | 2020 | 59 | 0.230 |
Why?
|
| Myocytes, Cardiac | 3 | 2026 | 670 | 0.230 |
Why?
|
| Heart Aneurysm | 1 | 2005 | 29 | 0.230 |
Why?
|
| Embolism | 1 | 2005 | 38 | 0.230 |
Why?
|
| Pulsatile Flow | 2 | 2019 | 110 | 0.230 |
Why?
|
| Microvessels | 1 | 2026 | 58 | 0.230 |
Why?
|
| Magnetics | 1 | 2025 | 32 | 0.220 |
Why?
|
| Thoracotomy | 3 | 2019 | 107 | 0.220 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 349 | 0.220 |
Why?
|
| Hospital Mortality | 7 | 2025 | 1057 | 0.220 |
Why?
|
| Body Size | 2 | 2017 | 62 | 0.220 |
Why?
|
| Methylprednisolone | 1 | 2025 | 94 | 0.220 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2000 | 100 | 0.210 |
Why?
|
| Truncus Arteriosus | 2 | 2021 | 13 | 0.210 |
Why?
|
| Cor Triatriatum | 1 | 2024 | 11 | 0.210 |
Why?
|
| Cellular Senescence | 1 | 2026 | 216 | 0.200 |
Why?
|
| Aorta | 2 | 2018 | 522 | 0.200 |
Why?
|
| Fibroblasts | 2 | 2025 | 850 | 0.200 |
Why?
|
| Coronary Disease | 2 | 2005 | 627 | 0.200 |
Why?
|
| Patient Selection | 2 | 2021 | 723 | 0.200 |
Why?
|
| Cattle | 4 | 2021 | 500 | 0.200 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2021 | 64 | 0.200 |
Why?
|
| Hirudins | 2 | 2022 | 39 | 0.200 |
Why?
|
| Respiratory Insufficiency | 2 | 2005 | 245 | 0.200 |
Why?
|
| Marfan Syndrome | 1 | 2005 | 144 | 0.200 |
Why?
|
| Ventricular Remodeling | 3 | 2024 | 154 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2021 | 247 | 0.200 |
Why?
|
| Incidental Findings | 1 | 2024 | 122 | 0.190 |
Why?
|
| Breast Neoplasms | 6 | 2000 | 2597 | 0.190 |
Why?
|
| Feasibility Studies | 2 | 2024 | 820 | 0.190 |
Why?
|
| Echocardiography | 6 | 2021 | 1131 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 298 | 0.190 |
Why?
|
| Catheters | 1 | 2022 | 79 | 0.180 |
Why?
|
| Atrial Flutter | 1 | 2022 | 44 | 0.180 |
Why?
|
| Coronary Angiography | 2 | 2019 | 449 | 0.180 |
Why?
|
| Airway Obstruction | 2 | 2016 | 173 | 0.180 |
Why?
|
| Transcriptome | 2 | 2025 | 1097 | 0.180 |
Why?
|
| Heart Bypass, Right | 2 | 2013 | 18 | 0.180 |
Why?
|
| Ventricular Function, Right | 2 | 2019 | 128 | 0.170 |
Why?
|
| Tracheal Stenosis | 2 | 2020 | 30 | 0.170 |
Why?
|
| Genetic Engineering | 1 | 2022 | 161 | 0.170 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 105 | 0.170 |
Why?
|
| Paclitaxel | 3 | 1996 | 129 | 0.170 |
Why?
|
| Models, Theoretical | 2 | 2014 | 358 | 0.170 |
Why?
|
| Intraoperative Complications | 2 | 2015 | 153 | 0.170 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 351 | 0.170 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 83 | 0.170 |
Why?
|
| Middle Aged | 23 | 2025 | 28314 | 0.170 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 736 | 0.170 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 155 | 0.170 |
Why?
|
| Factor VIIa | 1 | 2020 | 21 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 2 | 2019 | 352 | 0.160 |
Why?
|
| Prospective Studies | 7 | 2024 | 6402 | 0.160 |
Why?
|
| Animals | 12 | 2026 | 33660 | 0.160 |
Why?
|
| Consensus | 2 | 2021 | 521 | 0.160 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2020 | 20 | 0.160 |
Why?
|
| Kidney Diseases | 2 | 2022 | 472 | 0.160 |
Why?
|
| Computer Simulation | 2 | 2020 | 668 | 0.160 |
Why?
|
| Shock | 1 | 2021 | 96 | 0.150 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 782 | 0.150 |
Why?
|
| Infusions, Intravenous | 3 | 2016 | 532 | 0.150 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2019 | 7 | 0.150 |
Why?
|
| Databases, Factual | 4 | 2025 | 1227 | 0.150 |
Why?
|
| Berlin | 1 | 2019 | 3 | 0.150 |
Why?
|
| Vascular Ring | 1 | 2019 | 7 | 0.150 |
Why?
|
| Shock, Septic | 1 | 2021 | 148 | 0.150 |
Why?
|
| Biological Products | 1 | 2021 | 143 | 0.150 |
Why?
|
| Hydrodynamics | 1 | 2019 | 28 | 0.150 |
Why?
|
| Heart Valves | 2 | 2009 | 52 | 0.150 |
Why?
|
| Thrombelastography | 1 | 2019 | 69 | 0.150 |
Why?
|
| Atrioventricular Node | 2 | 2009 | 18 | 0.150 |
Why?
|
| American Heart Association | 1 | 2021 | 338 | 0.150 |
Why?
|
| E-Selectin | 1 | 1999 | 38 | 0.140 |
Why?
|
| Pulmonary Veins | 1 | 2021 | 167 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 629 | 0.140 |
Why?
|
| Overweight | 1 | 2021 | 381 | 0.140 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 125 | 0.140 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 138 | 0.140 |
Why?
|
| Platelet Activation | 1 | 2018 | 64 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 210 | 0.130 |
Why?
|
| Blood Coagulation Tests | 2 | 2019 | 65 | 0.130 |
Why?
|
| Aortic Arch Syndromes | 3 | 2014 | 11 | 0.130 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 700 | 0.130 |
Why?
|
| Tetralogy of Fallot | 2 | 2022 | 171 | 0.130 |
Why?
|
| Angiography | 2 | 2010 | 181 | 0.130 |
Why?
|
| Benchmarking | 1 | 2018 | 138 | 0.130 |
Why?
|
| Survival Analysis | 4 | 2017 | 1481 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1478 | 0.130 |
Why?
|
| Cohort Studies | 7 | 2024 | 5034 | 0.130 |
Why?
|
| Walking | 1 | 2019 | 230 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 1800 | 0.130 |
Why?
|
| Pectus Carinatum | 1 | 2017 | 5 | 0.130 |
Why?
|
| Digestive System Abnormalities | 1 | 2017 | 38 | 0.130 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 191 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 325 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1120 | 0.120 |
Why?
|
| Recurrence | 2 | 2018 | 1475 | 0.120 |
Why?
|
| Cardiotoxicity | 1 | 2017 | 48 | 0.120 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 2290 | 0.120 |
Why?
|
| Sheep | 1 | 2017 | 220 | 0.120 |
Why?
|
| Advanced Cardiac Life Support | 2 | 2013 | 18 | 0.120 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 332 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2000 | 1265 | 0.120 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 56 | 0.120 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 227 | 0.120 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 139 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 997 | 0.120 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2017 | 43 | 0.120 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2018 | 105 | 0.120 |
Why?
|
| Pulmonary Circulation | 2 | 2022 | 113 | 0.120 |
Why?
|
| Blood Circulation | 1 | 2016 | 14 | 0.120 |
Why?
|
| Endothelial Cells | 3 | 2025 | 520 | 0.120 |
Why?
|
| Milrinone | 1 | 2016 | 30 | 0.120 |
Why?
|
| Energy Intake | 1 | 2018 | 502 | 0.120 |
Why?
|
| Organotechnetium Compounds | 1 | 1995 | 11 | 0.120 |
Why?
|
| Abdominal Muscles | 1 | 2015 | 28 | 0.120 |
Why?
|
| Bronchial Arteries | 1 | 2015 | 4 | 0.120 |
Why?
|
| Taxoids | 1 | 1996 | 73 | 0.120 |
Why?
|
| Organophosphorus Compounds | 1 | 1995 | 26 | 0.110 |
Why?
|
| Dipyridamole | 1 | 1995 | 20 | 0.110 |
Why?
|
| Thoracic Wall | 1 | 2016 | 40 | 0.110 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2016 | 61 | 0.110 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 82 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1592 | 0.110 |
Why?
|
| Stroke Volume | 2 | 2017 | 536 | 0.110 |
Why?
|
| Hemorrhage | 2 | 2022 | 485 | 0.110 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 114 | 0.110 |
Why?
|
| Autopsy | 3 | 2009 | 113 | 0.110 |
Why?
|
| Primary Graft Dysfunction | 1 | 2015 | 41 | 0.110 |
Why?
|
| Cause of Death | 1 | 2017 | 502 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2017 | 1241 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 848 | 0.110 |
Why?
|
| Anemia | 1 | 2018 | 352 | 0.110 |
Why?
|
| Bronchoscopy | 2 | 2015 | 178 | 0.110 |
Why?
|
| Cyanosis | 1 | 2014 | 41 | 0.110 |
Why?
|
| Perioperative Period | 1 | 2014 | 48 | 0.110 |
Why?
|
| Trisomy | 1 | 2014 | 111 | 0.100 |
Why?
|
| Anastomosis, Surgical | 3 | 2014 | 176 | 0.100 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 215 | 0.100 |
Why?
|
| Elementary Particle Interactions | 1 | 2013 | 3 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2018 | 803 | 0.100 |
Why?
|
| Prosthesis Fitting | 1 | 2013 | 10 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2022 | 1319 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2010 | 1344 | 0.100 |
Why?
|
| Body Weight | 1 | 2017 | 985 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1874 | 0.090 |
Why?
|
| Prognosis | 4 | 2023 | 4848 | 0.090 |
Why?
|
| Electrocardiography | 3 | 2013 | 972 | 0.090 |
Why?
|
| Phenotype | 1 | 2022 | 4456 | 0.090 |
Why?
|
| Incidence | 4 | 2024 | 3321 | 0.090 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2015 | 474 | 0.090 |
Why?
|
| Aged | 18 | 2021 | 20821 | 0.090 |
Why?
|
| Dissection | 2 | 2009 | 55 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 59 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 1069 | 0.090 |
Why?
|
| Sternotomy | 1 | 2012 | 42 | 0.090 |
Why?
|
| Thermodynamics | 1 | 2012 | 144 | 0.090 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2012 | 79 | 0.090 |
Why?
|
| Tomography, Spiral Computed | 1 | 2011 | 14 | 0.090 |
Why?
|
| Vindesine | 1 | 1991 | 1 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2015 | 400 | 0.090 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2011 | 19 | 0.090 |
Why?
|
| Societies, Medical | 3 | 2025 | 791 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 227 | 0.080 |
Why?
|
| Diastole | 2 | 2011 | 181 | 0.080 |
Why?
|
| Equipment Safety | 1 | 2011 | 34 | 0.080 |
Why?
|
| Cardiomegaly | 2 | 2005 | 118 | 0.080 |
Why?
|
| Assisted Circulation | 1 | 2011 | 23 | 0.080 |
Why?
|
| Disease Management | 1 | 2015 | 554 | 0.080 |
Why?
|
| Aortography | 1 | 2011 | 152 | 0.080 |
Why?
|
| Elastic Tissue | 1 | 2010 | 18 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 304 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2009 | 2076 | 0.080 |
Why?
|
| Obesity | 2 | 2021 | 2398 | 0.080 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 1393 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 295 | 0.080 |
Why?
|
| Organ Size | 1 | 2011 | 408 | 0.080 |
Why?
|
| Heart Septum | 1 | 2009 | 44 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2014 | 353 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2015 | 747 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2010 | 182 | 0.080 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 242 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 641 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 484 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2009 | 76 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 1999 | 96 | 0.070 |
Why?
|
| Fibrosis | 2 | 2025 | 420 | 0.070 |
Why?
|
| Cadaver | 1 | 2009 | 114 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 365 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 890 | 0.070 |
Why?
|
| Oxygen | 1 | 2012 | 549 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 969 | 0.070 |
Why?
|
| Pneumonectomy | 1 | 2009 | 154 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2057 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 293 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2015 | 1042 | 0.070 |
Why?
|
| Fetal Heart | 1 | 2009 | 132 | 0.070 |
Why?
|
| Venae Cavae | 1 | 2007 | 10 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2009 | 294 | 0.070 |
Why?
|
| Heart Conduction System | 1 | 2008 | 163 | 0.070 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2007 | 6 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2022 | 687 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 342 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 91 | 0.060 |
Why?
|
| Quality of Life | 2 | 2015 | 2069 | 0.060 |
Why?
|
| Iodine Radioisotopes | 2 | 1997 | 65 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2008 | 226 | 0.060 |
Why?
|
| Polyglycolic Acid | 2 | 1996 | 23 | 0.060 |
Why?
|
| Trachea | 2 | 2020 | 206 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2000 | 713 | 0.060 |
Why?
|
| Body Composition | 2 | 2019 | 543 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4639 | 0.060 |
Why?
|
| Lactic Acid | 2 | 1996 | 145 | 0.060 |
Why?
|
| Microcirculation | 1 | 2006 | 104 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 356 | 0.060 |
Why?
|
| Swine | 2 | 2021 | 1184 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2019 | 345 | 0.060 |
Why?
|
| Spirometry | 1 | 2005 | 92 | 0.060 |
Why?
|
| Exercise | 1 | 2011 | 881 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2023 | 4645 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 1547 | 0.050 |
Why?
|
| Withholding Treatment | 1 | 2024 | 76 | 0.050 |
Why?
|
| Ductus Arteriosus | 1 | 2024 | 61 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2015 | 902 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2022 | 12 | 0.050 |
Why?
|
| Image Cytometry | 1 | 2022 | 18 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 24 | 0.050 |
Why?
|
| Thorax | 1 | 2022 | 62 | 0.050 |
Why?
|
| Reference Values | 2 | 2017 | 674 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 448 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1374 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2005 | 500 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2022 | 253 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2000 | 1325 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2022 | 291 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 723 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 71 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2022 | 153 | 0.040 |
Why?
|
| ROC Curve | 1 | 2023 | 609 | 0.040 |
Why?
|
| Lung | 2 | 2021 | 1531 | 0.040 |
Why?
|
| Comorbidity | 2 | 2017 | 1584 | 0.040 |
Why?
|
| Iodobenzenes | 2 | 1997 | 2 | 0.040 |
Why?
|
| Adjustment Disorders | 1 | 2000 | 5 | 0.040 |
Why?
|
| Vinblastine | 1 | 2000 | 54 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 335 | 0.040 |
Why?
|
| Replantation | 1 | 2020 | 51 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2019 | 33 | 0.040 |
Why?
|
| Retreatment | 1 | 2020 | 85 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 373 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 148 | 0.040 |
Why?
|
| Doxorubicin | 3 | 2000 | 289 | 0.040 |
Why?
|
| Patients | 1 | 2000 | 122 | 0.040 |
Why?
|
| Technetium Tc 99m Mertiatide | 1 | 1999 | 1 | 0.040 |
Why?
|
| Radioisotope Renography | 1 | 1999 | 3 | 0.040 |
Why?
|
| Polymers | 2 | 1996 | 103 | 0.040 |
Why?
|
| Hypothermia, Induced | 1 | 2020 | 169 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1800 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 251 | 0.040 |
Why?
|
| Cyclophosphamide | 3 | 2000 | 425 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2018 | 87 | 0.030 |
Why?
|
| Bisoprolol | 1 | 1997 | 7 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 145 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2022 | 686 | 0.030 |
Why?
|
| Thallium Radioisotopes | 1 | 1997 | 4 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1279 | 0.030 |
Why?
|
| Chitin | 1 | 1996 | 6 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1999 | 410 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 422 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3349 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1210 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1439 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Linear Models | 1 | 2018 | 686 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 1996 | 34 | 0.030 |
Why?
|
| Carcinoma, Medullary | 1 | 1996 | 17 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2191 | 0.030 |
Why?
|
| Aortic Aneurysm | 3 | 1983 | 222 | 0.030 |
Why?
|
| Bronchi | 1 | 2016 | 98 | 0.030 |
Why?
|
| Alopecia | 1 | 1996 | 41 | 0.030 |
Why?
|
| Leukopenia | 1 | 1996 | 44 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 371 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1694 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1997 | 216 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 215 | 0.030 |
Why?
|
| Tamoxifen | 2 | 2000 | 348 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 91 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2000 | 532 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1406 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 189 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 1935 | 0.030 |
Why?
|
| Cisplatin | 1 | 1996 | 274 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 2015 | 110 | 0.030 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2014 | 17 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 1996 | 425 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 59 | 0.030 |
Why?
|
| Neutropenia | 1 | 1996 | 209 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1343 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2000 | 907 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2015 | 589 | 0.020 |
Why?
|
| Fluorodeoxyuridylate | 1 | 1993 | 1 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 98 | 0.020 |
Why?
|
| Thymidylate Synthase | 1 | 1993 | 20 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2014 | 181 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 6765 | 0.020 |
Why?
|
| Microspheres | 3 | 1996 | 66 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 191 | 0.020 |
Why?
|
| Photons | 1 | 2012 | 60 | 0.020 |
Why?
|
| Particle Size | 3 | 1996 | 134 | 0.020 |
Why?
|
| Inhalation | 1 | 2012 | 8 | 0.020 |
Why?
|
| Vacuoles | 1 | 1992 | 28 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2012 | 27 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 259 | 0.020 |
Why?
|
| Proton-Translocating ATPases | 1 | 1992 | 25 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2012 | 73 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2017 | 863 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 361 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2687 | 0.020 |
Why?
|
| Pregnancy | 1 | 2024 | 7390 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 470 | 0.020 |
Why?
|
| Folic Acid | 1 | 1993 | 269 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 563 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1991 | 242 | 0.020 |
Why?
|
| Remission Induction | 1 | 1991 | 306 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1991 | 82 | 0.020 |
Why?
|
| Japan | 2 | 2000 | 160 | 0.020 |
Why?
|
| Chordae Tendineae | 1 | 2008 | 12 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 968 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 18160 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 305 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1991 | 728 | 0.020 |
Why?
|
| Critical Care | 1 | 2013 | 686 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3741 | 0.020 |
Why?
|
| Myristates | 2 | 1996 | 3 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2322 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 1993 | 612 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2007 | 222 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1996 | 115 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 356 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 121 | 0.020 |
Why?
|
| Epilepsy | 1 | 1994 | 864 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1282 | 0.010 |
Why?
|
| Drug Carriers | 2 | 1996 | 118 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 1366 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 2007 | 194 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3782 | 0.010 |
Why?
|
| Achlorhydria | 1 | 1984 | 6 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1984 | 17 | 0.010 |
Why?
|
| Hypokalemia | 1 | 1984 | 41 | 0.010 |
Why?
|
| Logistic Models | 2 | 2000 | 1794 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2574 | 0.010 |
Why?
|
| Biomarkers | 1 | 2012 | 3358 | 0.010 |
Why?
|
| Diarrhea | 1 | 1984 | 299 | 0.010 |
Why?
|
| Brain | 1 | 1994 | 3146 | 0.010 |
Why?
|
| Emergencies | 1 | 1983 | 170 | 0.010 |
Why?
|
| Medroxyprogesterone | 1 | 2000 | 9 | 0.010 |
Why?
|
| Life Tables | 1 | 2000 | 24 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1979 | 15 | 0.010 |
Why?
|
| Affect | 1 | 2000 | 160 | 0.010 |
Why?
|
| Aortic Rupture | 1 | 1979 | 112 | 0.010 |
Why?
|
| Social Support | 1 | 2000 | 369 | 0.010 |
Why?
|
| Pain | 1 | 2000 | 431 | 0.010 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 1997 | 12 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1997 | 113 | 0.010 |
Why?
|
| Body Surface Potential Mapping | 1 | 1997 | 18 | 0.010 |
Why?
|
| Adsorption | 1 | 1996 | 33 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2000 | 903 | 0.010 |
Why?
|
| Chitosan | 1 | 1996 | 27 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1996 | 263 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 587 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 362 | 0.010 |
Why?
|
| Area Under Curve | 1 | 1996 | 303 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1997 | 373 | 0.010 |
Why?
|
| Software | 1 | 1999 | 733 | 0.010 |
Why?
|
| Tegafur | 1 | 1993 | 1 | 0.010 |
Why?
|
| Uracil | 1 | 1993 | 12 | 0.010 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1994 | 92 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 167 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 203 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 234 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 252 | 0.010 |
Why?
|
| Dogs | 1 | 1992 | 615 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 975 | 0.000 |
Why?
|
| Binding Sites | 1 | 1993 | 1134 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1994 | 849 | 0.000 |
Why?
|
| Neoplasms | 1 | 1984 | 2975 | 0.000 |
Why?
|
| RNA | 1 | 1992 | 509 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 1453 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2392 | 0.000 |
Why?
|
| Base Sequence | 1 | 1992 | 2729 | 0.000 |
Why?
|
| Gene Expression | 1 | 1992 | 1482 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 3464 | 0.000 |
Why?
|
| Cell Line | 1 | 1992 | 2554 | 0.000 |
Why?
|
| DNA | 1 | 1992 | 1398 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1984 | 82 | 0.000 |
Why?
|
| Mediastinal Neoplasms | 1 | 1984 | 36 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1984 | 63 | 0.000 |
Why?
|
| Cerebrovascular Disorders | 1 | 1982 | 111 | 0.000 |
Why?
|
| Syndrome | 1 | 1984 | 1157 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1984 | 735 | 0.000 |
Why?
|